{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:05:19Z","timestamp":1774976719518,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2025JJ70142"],"award-info":[{"award-number":["2025JJ70142"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2025JJ70142"],"award-info":[{"award-number":["2025JJ70142"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nature Science Foundation of Guangxi","award":["2025GXNSFDA069004"],"award-info":[{"award-number":["2025GXNSFDA069004"]}]},{"name":"Nature Science Foundation of Guangxi","award":["2025GXNSFDA069004"],"award-info":[{"award-number":["2025GXNSFDA069004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-01996-0","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:48:18Z","timestamp":1772077698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nicotinamide mononucleotide attenuates hyperandrogenism in a polycystic ovary syndrome-like rat model by suppressing NLRP3 inflammasome\u2013mediated granulosa-cell pyroptosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Yiwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kongwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Nong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"1996_CR1","doi-asserted-by":"crossref","unstructured":"Yang J, Chen C. Hormonal changes in PCOS. J Endocrinol. 2024;261(1):JOE-23-0342.","DOI":"10.1530\/JOE-23-0342"},{"issue":"6","key":"1996_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022;43(6):927\u201365.","journal-title":"Endocr Rev"},{"issue":"4","key":"1996_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21(4):230\u201344.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"1996_CR4","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, Mateen S, Ahmad R, et al. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439\u201373.","journal-title":"J Assist Reprod Genet"},{"key":"1996_CR5","doi-asserted-by":"publisher","first-page":"1358755","DOI":"10.3389\/fcell.2024.1358755","volume":"12","author":"A Joshi","year":"2024","unstructured":"Joshi A. PCOS stratification for precision diagnostics and treatment. Front Cell Dev Biol. 2024;12:1358755.","journal-title":"Front Cell Dev Biol"},{"key":"1996_CR6","doi-asserted-by":"publisher","first-page":"102311","DOI":"10.1016\/j.coph.2022.102311","volume":"67","author":"T Capezzuoli","year":"2022","unstructured":"Capezzuoli T, Rossi M, La Torre F, et al. Hormonal drugs for the treatment of endometriosis. Curr Opin Pharmacol. 2022;67:102311.","journal-title":"Curr Opin Pharmacol"},{"key":"1996_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6701","key":"1996_CR8","doi-asserted-by":"publisher","first-page":"eadk5382","DOI":"10.1126\/science.adk5382","volume":"384","author":"Y Liu","year":"2024","unstructured":"Liu Y, Jiang JJ, Du SY, et al. Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction. Science. 2024;384(6701):eadk5382.","journal-title":"Science"},{"key":"1996_CR9","doi-asserted-by":"publisher","first-page":"741764","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, et al. Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:741764.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1996_CR10","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41598-022-08400-z","volume":"12","author":"S Kadoura","year":"2022","unstructured":"Kadoura S, Alhalabi M, Nattouf AH. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis. Sci Rep. 2022;12(1):4456.","journal-title":"Sci Rep"},{"issue":"1","key":"1996_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13048-022-01078-x","volume":"16","author":"G Xu","year":"2023","unstructured":"Xu G, Zhao X, Li Z, et al. Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) \/luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin\/neurokinin B\/dynorphin neurons in PCOS rats. J Ovarian Res. 2023;16(1):15.","journal-title":"J Ovarian Res"},{"key":"1996_CR12","doi-asserted-by":"publisher","first-page":"667422","DOI":"10.3389\/fendo.2021.667422","volume":"12","author":"B Liao","year":"2021","unstructured":"Liao B, Qiao J, Pang Y. Central regulation of PCOS: abnormal Neuronal-Reproductive-Metabolic circuits in PCOS pathophysiology. Front Endocrinol (Lausanne). 2021;12:667422.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1996_CR13","doi-asserted-by":"crossref","unstructured":"Rudnicka E, Suchta K, Grymowicz M, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3785.","DOI":"10.3390\/ijms22073789"},{"key":"1996_CR14","doi-asserted-by":"crossref","unstructured":"Armanini D, Boscaro M, Bordin L, et al. Controversies in the Pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110.","DOI":"10.3390\/ijms23084110"},{"key":"1996_CR15","doi-asserted-by":"publisher","first-page":"685724","DOI":"10.3389\/fimmu.2021.685724","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu H, Li Z, et al. The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment. Front Immunol. 2021;12:685724.","journal-title":"Front Immunol"},{"key":"1996_CR16","doi-asserted-by":"crossref","unstructured":"Alenezi SA, Khan R, Snell L, et al. The role of NLRP3 inflammasome in obesity and PCOS-A systematic review and meta-analysis. Int J Mol Sci. 2023;24(13):10976.","DOI":"10.3390\/ijms241310976"},{"issue":"1","key":"1996_CR17","doi-asserted-by":"publisher","first-page":"e23592","DOI":"10.1002\/jbt.23592","volume":"38","author":"S Chamanara","year":"2024","unstructured":"Chamanara S, Hozouri V, Irandoost E. Inhibition of NLRP3 inflammasome-A potential mechanistic therapeutic for treatment of polycystic ovary syndrome? J Biochem Mol Toxicol. 2024;38(1):e23592.","journal-title":"J Biochem Mol Toxicol"},{"issue":"21","key":"1996_CR18","doi-asserted-by":"publisher","first-page":"e2400340","DOI":"10.1002\/mnfr.202400340","volume":"68","author":"W Zhang","year":"2024","unstructured":"Zhang W, Zhang J, Xue H, et al. Nicotinamide mononucleotide improves endometrial homeostasis in a rat model of polycystic ovary syndrome by decreasing insulin resistance and regulating the glylytic pathway. Mol Nutr Food Res. 2024;68(21):e2400340.","journal-title":"Mol Nutr Food Res"},{"key":"1996_CR19","doi-asserted-by":"crossref","unstructured":"Ren C, Zhang S, Ma J, et al. Nicotinamide mononucleotide alleviates bile acid metabolism and hormonal dysregulation in Letrozole-Induced PCOS mice. Biology (Basel). 2024;13(12):1028.","DOI":"10.3390\/biology13121028"},{"key":"1996_CR20","doi-asserted-by":"crossref","unstructured":"Ahmed M, Riaz U, Lv H, et al. Nicotinamide mononucleotide restores NAD(+) levels to alleviate LPS-Induced inflammation via the TLR4\/NF-\u03baB\/MAPK signaling pathway in mice granulosa cells. Antioxid (Basel). 2024;14(1):39.","DOI":"10.3390\/antiox14010039"},{"key":"1996_CR21","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.freeradbiomed.2024.10.312","volume":"225","author":"K Liu","year":"2024","unstructured":"Liu K, Wei H, Nong W, et al. Nampt\/SIRT2\/LDHA pathway-mediated lactate production regulates follicular dysplasia in polycystic ovary syndrome. Free Radic Biol Med. 2024;225:776\u201393.","journal-title":"Free Radic Biol Med"},{"key":"1996_CR22","first-page":"e922136","volume":"26","author":"MX Wang","year":"2020","unstructured":"Wang MX, Yin Q, Xu X. A rat model of polycystic ovary syndrome with insulin resistance induced by letrozole combined with high fat diet. Med Sci Monit. 2020;26:e922136.","journal-title":"Med Sci Monit"},{"key":"1996_CR23","doi-asserted-by":"publisher","first-page":"119753","DOI":"10.1016\/j.lfs.2021.119753","volume":"280","author":"L Corrie","year":"2021","unstructured":"Corrie L, Gulati M, Singh SK, et al. Recent updates on animal models for Understanding the etiopathogenesis of polycystic ovarian syndrome. Life Sci. 2021;280:119753.","journal-title":"Life Sci"},{"issue":"3","key":"1996_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/092986707779941087","volume":"14","author":"N Suzumori","year":"2007","unstructured":"Suzumori N, Pangas SA, Rajkovic A. Candidate genes for premature ovarian failure. Curr Med Chem. 2007;14(3):353\u20137.","journal-title":"Curr Med Chem"},{"issue":"11","key":"1996_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.autrev.2010.06.008","volume":"9","author":"S Dragojevi\u0107-Diki\u0107","year":"2010","unstructured":"Dragojevi\u0107-Diki\u0107 S, Marisavljevi\u0107 D, Mitrovi\u0107 A, et al. An immunological insight into premature ovarian failure (POF). Autoimmun Rev. 2010;9(11):771\u20134.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"1996_CR26","doi-asserted-by":"publisher","first-page":"e22591","DOI":"10.1002\/jbt.22591","volume":"34","author":"Y Yao","year":"2020","unstructured":"Yao Y, Xu Y, Wang Y. Protective roles and mechanisms of Rosmarinic acid in cyclophosphamide-induced premature ovarian failure. J Biochem Mol Toxicol. 2020;34(12):e22591.","journal-title":"J Biochem Mol Toxicol"},{"key":"1996_CR27","doi-asserted-by":"publisher","first-page":"1324429","DOI":"10.3389\/fendo.2023.1324429","volume":"14","author":"M Orisaka","year":"2023","unstructured":"Orisaka M, Mizutani T, Miyazaki Y, et al. Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging. Front Endocrinol (Lausanne). 2023;14:1324429.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1996_CR28","doi-asserted-by":"crossref","unstructured":"Borzan V, Lerchbaum E, Missbrenner C et al. Risk of insulin resistance and metabolic syndrome in women with hyperandrogenemia: a comparison between PCOS phenotypes and beyond. J Clin Med. 2021;10(4):829.","DOI":"10.3390\/jcm10040829"},{"issue":"1","key":"1996_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/humupd\/dmq032","volume":"17","author":"J Qiao","year":"2011","unstructured":"Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17(1):17\u201333.","journal-title":"Hum Reprod Update"},{"key":"1996_CR30","doi-asserted-by":"publisher","first-page":"815968","DOI":"10.3389\/fendo.2022.815968","volume":"13","author":"B Liao","year":"2022","unstructured":"Liao B, Qi X, Yun C, et al. Effects of androgen Excess-Related metabolic disturbances on granulosa cell function and follicular development. Front Endocrinol (Lausanne). 2022;13:815968.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1996_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino J, Mills KF, Yoon MJ, et al. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14(4):528\u201336.","journal-title":"Cell Metab"},{"issue":"5","key":"1996_CR32","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1002\/jcp.27501","volume":"234","author":"Y Li","year":"2019","unstructured":"Li Y, Zheng Q, Sun D, et al. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome. J Cell Physiol. 2019;234(5):7435\u201347.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1996_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13048-024-01525-x","volume":"17","author":"D Tian","year":"2024","unstructured":"Tian D, Chen J, Liu L. Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional Mendelian randomization study. J Ovarian Res. 2024;17(1):217.","journal-title":"J Ovarian Res"},{"key":"1996_CR34","doi-asserted-by":"publisher","first-page":"1435698","DOI":"10.3389\/fendo.2024.1435698","volume":"15","author":"M W\u00e4lchli-Popovic","year":"2024","unstructured":"W\u00e4lchli-Popovic M, Monnerat S, Taylor AE, et al. Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome-the fertil trial. Front Endocrinol (Lausanne). 2024;15:1435698.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1996_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0035-1554928","volume":"33","author":"CE Boots","year":"2015","unstructured":"Boots CE, Jungheim ES. Inflammation and human ovarian follicular dynamics. Semin Reprod Med. 2015;33(4):270\u20135.","journal-title":"Semin Reprod Med"},{"issue":"5","key":"1996_CR36","first-page":"569","volume":"60","author":"MR Garc\u00eda-S\u00e1enz","year":"2022","unstructured":"Garc\u00eda-S\u00e1enz MR, Ferreira-Hermosillo A, Lobaton-Ginsberg M. Proinflammatory cytokines in polycystic ovarian syndrome. Rev Med Inst Mex Seguro Soc. 2022;60(5):569\u201376.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"1","key":"1996_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41598-020-79488-4","volume":"11","author":"C Lliberos","year":"2021","unstructured":"Lliberos C, Liew SH, Zareie P, et al. Evaluation of inflammation and follicle depletion during ovarian ageing in mice. Sci Rep. 2021;11(1):278.","journal-title":"Sci Rep"},{"issue":"3","key":"1996_CR38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","volume":"303","author":"S Abraham Gnanadass","year":"2021","unstructured":"Abraham Gnanadass S, Divakar Prabhu Y, Valsala A, Gopalakrishnan. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631\u201343.","journal-title":"Arch Gynecol Obstet"},{"issue":"6046","key":"1996_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.1201940","volume":"333","author":"DR Green","year":"2011","unstructured":"Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 2011;333(6046):1109\u201312.","journal-title":"Science"},{"issue":"2","key":"1996_CR40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ddr.22027","volume":"84","author":"X Ji","year":"2023","unstructured":"Ji X, Ye Y, Wang L, et al. PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro. Drug Dev Res. 2023;84(2):226\u201337.","journal-title":"Drug Dev Res"},{"issue":"3","key":"1996_CR41","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/biolre\/ioae094","volume":"111","author":"W Ye","year":"2024","unstructured":"Ye W, Xia S, Xie T, et al. Klotho accelerates the progression of polycystic ovary syndrome through promoting granulosa cell apoptosis and inflammation\u2020. Biol Reprod. 2024;111(3):625\u201339.","journal-title":"Biol Reprod"},{"issue":"11","key":"1996_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1055\/a-0992-9114","volume":"128","author":"E Hatziagelaki","year":"2020","unstructured":"Hatziagelaki E, Pergialiotis V, Kannenberg JM, et al. Association between biomarkers of Low-grade inflammation and sex hormones in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2020;128(11):723\u201330.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"1996_CR43","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Lecke SB, Satler F, et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219\u201327.","journal-title":"Reproduction"},{"issue":"6","key":"1996_CR44","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/biolre\/ioab050","volume":"104","author":"LM Velez","year":"2021","unstructured":"Velez LM, Seldin M, Motta AB. Inflammation and reproductive function in women with polycystic ovary syndrome\u2020. Biol Reprod. 2021;104(6):1205\u201317.","journal-title":"Biol Reprod"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-01996-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-01996-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-01996-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:01:00Z","timestamp":1774972860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-01996-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-01996-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}